| Literature DB >> 2854367 |
E A Falase1, E O Otolorin, O A Ladipo.
Abstract
Eight hundred and ten patients who accepted to use depo-medroxyprogesterone acetate (DMPA) for contraception were studied over a period of 11 years (1976-1986). Important side-effects observed were amenorrhoea (36.3%), weight gain (15.8%), weight loss (10.6%), metrorrhagia (6.7%) and menorrhagia (6.0%). Amenorrhoea, menorrhagia and metrorrhagia were major reasons for discontinuation of DMPA in 11% of acceptors. There were no cases of pregnancy, genital or breast malignancies during DMPA use. Our experience indicates that DMPA as a contraceptive is effective and should be available for suitable clients who demonstrate oestrogen intolerance.Entities:
Keywords: Africa; Africa South Of The Sahara; Contraception; Contraception Continuation; Contraception Termination; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Methods; Contraceptive Usage; Depo-provera; Developing Countries; English Speaking Africa; Family Planning; Injectables; Medroxyprogesterone Acetate; Nigeria; Western Africa
Mesh：
Substances：
Year: 1988 PMID： 2854367
Source DB: PubMed Journal: Afr J Med Med Sci ISSN： 0309-3913